mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.3 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.3 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.3 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |